Condition
Chemotherapy-induced Nausea and Vomiting clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Chemotherapy-induced Nausea and Vomiting clinical trials that are recruiting, at sites in 4 countries (most in China (3), Thailand (1), United States (1)). By phase: Phase 3 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Chemotherapy-induced Nausea and Vomiting clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fosaprepitant plus palonosetron with dexamethasone (± olanzapine) to prevent nausea from multi-day highly emetogenic chemotherapy | Phase 4 | Shanghai, Shanghai Municipality | Recruiting | Mar 19, 2026 |
| Comparing olanzapine to placebo for preventing nausea from chemotherapy | Phase 3 | Bangkok, Bangkok | Recruiting | Feb 27, 2025 |
| Using Dolasetron to Prevent Nausea and Vomiting in Children with Leukemia | — | Hefei, Anhui | Recruiting | Jan 1, 2025 |
| Using guided imagery to reduce nausea and vomiting in children undergoing chemotherapy | — | Ankara, Ankara | Recruiting | Nov 7, 2023 |
| Using Thalidomide to Reduce Nausea from Chemotherapy in Pancreatic Cancer | Phase 3 | Shanghai, Shanghai Municipality | Recruiting | Aug 30, 2023 |
| Using digital technology to manage chemotherapy-related nausea and vomiting in older adults | — | Miami, Florida and 1 other locations | Recruiting | May 1, 2023 |
All recruiting trials (6)
-
Fosaprepitant plus palonosetron with dexamethasone (± olanzapine) to prevent nausea from multi-day highly emetogenic chemotherapy
This trial tests whether giving fosaprepitant and palonosetron with dexamethasone, with or without olanzapine, can prevent nausea and vomiting in adults starting multi-day highly emetogenic chemotherapy.
-
Comparing olanzapine to placebo for preventing nausea from chemotherapy
This study tests if the medication olanzapine can help prevent nausea and vomiting in people getting chemotherapy for the first time.
-
Using Dolasetron to Prevent Nausea and Vomiting in Children with Leukemia
This study is testing if dolasetron can help prevent nausea and vomiting in children with leukemia who are receiving chemotherapy.
-
Using guided imagery to reduce nausea and vomiting in children undergoing chemotherapy
This study is testing if using guided imagery can help reduce nausea and vomiting in children aged 7 to 18 who are receiving chemotherapy.
-
Using Thalidomide to Reduce Nausea from Chemotherapy in Pancreatic Cancer
This study is testing if thalidomide can help reduce nausea and improve the quality of life for people with pancreatic cancer who are receiving chemotherapy.
-
Using digital technology to manage chemotherapy-related nausea and vomiting in older adults
This study is testing a digital program to help older adults manage nausea and vomiting while they go through chemotherapy to see if it improves their quality of life.
Related topics
Quick answers
How many Chemotherapy-induced Nausea and Vomiting clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (3 trials), Thailand (1 trial), United States (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.